Standout Papers

Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease 2010 2026 2015 2020 537
  1. Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease (2010)
    Christopher P. Cannon, Sukrut Shah et al. New England Journal of Medicine

Citation Impact

1 by Nobel laureates 14 from Science/Nature 58 standout
Sub-graph 1 of 19

Citing Papers

Segmental duplications and their variation in a complete human genome
2022 StandoutScience
The changing landscape of atherosclerosis
2021 StandoutNature
2 intermediate papers

Works of Michael Stepanavage being referenced

Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease
2010 Standout

Author Peers

Author Surgery EDM EE Cancer Research Last Decade Papers Cites
Michael Stepanavage 891 531 163 254 15 1.3k
G.E. Pollott 5 7 3 38 34 840
C.W. Surovic 20 559
Kate Baicy 4 17 3 8 617
C Druilhe 94 6 262
Savannah G. Sims 20 6 3 7 364

All Works

Loading papers...

Rankless by CCL
2026